NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|4505163|ref|NP_002399|]
View 

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase precursor [Homo sapiens]

Protein Classification

MGAT2 domain-containing protein( domain architecture ID 10523720)

MGAT2 domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MGAT2 pfam05060
N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside ...
92-440 0e+00

N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside beta-1,2-N- acetylglucosaminyltransferase II (EC 2.4.1.143) (GnT II/MGAT2) is a Golgi resident enzyme that catalyzes an essential step in the biosynthetic pathway leading from high mannose to complex N-linked oligosaccharides. Mutations in the MGAT2 gene lead to congenital disorder of glycosylation (CDG IIa). CDG IIa patients have an increased bleeding tendency, unrelated to coagulation factors.


:

Pssm-ID: 461539  Cd Length: 349  Bit Score: 670.91  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163     92 RSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCP 171
Cdd:pfam05060   1 RNSIYQLNFRQTILNLDKFPSLAPDSLVIVVQVHNRPEYLRLLIESLRKARGIENALLIFSHDFYSEEINRLVQSIDFCR 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    172 VLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDY 251
Cdd:pfam05060  81 VLQIFFPYSLQLYPNEFPGQDPNDCPRDISKEDALKKGCNNAEYPDSYGHYREAKFTQTKHHWWWKLNFVFDRLRVTKGY 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    252 AGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKL 331
Cdd:pfam05060 161 NGLVLFLEEDHYVAPDFYHVLKLMVKLKPSECPDCDILSLGNYDKLSNYYSLSDKVEVKGWISTKHNMGMAFNRDTWYKI 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    332 IECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHK-KTCRPSTQSAQIESLLNNNKQYMFPET 410
Cdd:pfam05060 241 KSCAEEFCTYDDYNWDWSLQHLSAKCLPSPLKVLVLRGPRVFHIGDCGLHHKgKDCRPEQAINKLEELLRSNKNYLFPKS 320
                         330       340       350
                  ....*....|....*....|....*....|
gi 4505163    411 LTISEKFTvVAISPPRKNGGWGDIRDHELC 440
Cdd:pfam05060 321 LTITKKTG-VAVKPPKKNGGWGDIRDHELC 349
 
Name Accession Description Interval E-value
MGAT2 pfam05060
N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside ...
92-440 0e+00

N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside beta-1,2-N- acetylglucosaminyltransferase II (EC 2.4.1.143) (GnT II/MGAT2) is a Golgi resident enzyme that catalyzes an essential step in the biosynthetic pathway leading from high mannose to complex N-linked oligosaccharides. Mutations in the MGAT2 gene lead to congenital disorder of glycosylation (CDG IIa). CDG IIa patients have an increased bleeding tendency, unrelated to coagulation factors.


Pssm-ID: 461539  Cd Length: 349  Bit Score: 670.91  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163     92 RSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCP 171
Cdd:pfam05060   1 RNSIYQLNFRQTILNLDKFPSLAPDSLVIVVQVHNRPEYLRLLIESLRKARGIENALLIFSHDFYSEEINRLVQSIDFCR 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    172 VLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDY 251
Cdd:pfam05060  81 VLQIFFPYSLQLYPNEFPGQDPNDCPRDISKEDALKKGCNNAEYPDSYGHYREAKFTQTKHHWWWKLNFVFDRLRVTKGY 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    252 AGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKL 331
Cdd:pfam05060 161 NGLVLFLEEDHYVAPDFYHVLKLMVKLKPSECPDCDILSLGNYDKLSNYYSLSDKVEVKGWISTKHNMGMAFNRDTWYKI 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    332 IECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHK-KTCRPSTQSAQIESLLNNNKQYMFPET 410
Cdd:pfam05060 241 KSCAEEFCTYDDYNWDWSLQHLSAKCLPSPLKVLVLRGPRVFHIGDCGLHHKgKDCRPEQAINKLEELLRSNKNYLFPKS 320
                         330       340       350
                  ....*....|....*....|....*....|
gi 4505163    411 LTISEKFTvVAISPPRKNGGWGDIRDHELC 440
Cdd:pfam05060 321 LTITKKTG-VAVKPPKKNGGWGDIRDHELC 349
 
Name Accession Description Interval E-value
MGAT2 pfam05060
N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside ...
92-440 0e+00

N-acetylglucosaminyltransferase II (MGAT2); UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside beta-1,2-N- acetylglucosaminyltransferase II (EC 2.4.1.143) (GnT II/MGAT2) is a Golgi resident enzyme that catalyzes an essential step in the biosynthetic pathway leading from high mannose to complex N-linked oligosaccharides. Mutations in the MGAT2 gene lead to congenital disorder of glycosylation (CDG IIa). CDG IIa patients have an increased bleeding tendency, unrelated to coagulation factors.


Pssm-ID: 461539  Cd Length: 349  Bit Score: 670.91  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163     92 RSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCP 171
Cdd:pfam05060   1 RNSIYQLNFRQTILNLDKFPSLAPDSLVIVVQVHNRPEYLRLLIESLRKARGIENALLIFSHDFYSEEINRLVQSIDFCR 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    172 VLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDY 251
Cdd:pfam05060  81 VLQIFFPYSLQLYPNEFPGQDPNDCPRDISKEDALKKGCNNAEYPDSYGHYREAKFTQTKHHWWWKLNFVFDRLRVTKGY 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    252 AGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKL 331
Cdd:pfam05060 161 NGLVLFLEEDHYVAPDFYHVLKLMVKLKPSECPDCDILSLGNYDKLSNYYSLSDKVEVKGWISTKHNMGMAFNRDTWYKI 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505163    332 IECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHK-KTCRPSTQSAQIESLLNNNKQYMFPET 410
Cdd:pfam05060 241 KSCAEEFCTYDDYNWDWSLQHLSAKCLPSPLKVLVLRGPRVFHIGDCGLHHKgKDCRPEQAINKLEELLRSNKNYLFPKS 320
                         330       340       350
                  ....*....|....*....|....*....|
gi 4505163    411 LTISEKFTvVAISPPRKNGGWGDIRDHELC 440
Cdd:pfam05060 321 LTITKKTG-VAVKPPKKNGGWGDIRDHELC 349
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH